uniQure Announces Results for the First Quarter 2014

Read More

Amsterdam, the Netherlands, June 6, 2014 — uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced results for the first quarter of 2014. As of March 31, 2014, the Company held cash and cash equivalents of €77.5 million.